Clinical Trials List
2026-06-01 - 2030-06-30
Phase III
Recruiting14
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- CHO-KAI WU Division of Cardiovascular Diseases
- 孟士瑋 Division of Cardiovascular Diseases
- Hsien Li Kao Division of Cardiovascular Diseases
- Chih-Fan Yeh Division of Cardiovascular Diseases
- 柯宗佑 Division of Cardiovascular Diseases
- 洪啟盛 Division of Cardiovascular Diseases
- JEN-KUANG LEE Division of Cardiovascular Diseases
- 賀立婷 Division of Cardiovascular Diseases
- Tzung-Dau Wang Division of Cardiovascular Diseases
- HUNG-JU LIN Division of Cardiovascular Diseases
- 林廷澤 Division of Cardiovascular Diseases
- MAO-HSIN LIN Division of Cardiovascular Diseases
- 李弘元 Division of Cardiovascular Diseases
- 林柏志 Division of Cardiovascular Diseases
- 黃慶昌 Division of Cardiovascular Diseases
- 陳俊凱 Division of Cardiovascular Diseases
- 蘇乾嘉 Division of Cardiovascular Diseases
- 陳盈憲 Division of Cardiovascular Diseases
- 鄭人方 Division of Cardiovascular Diseases
- 蔡承烜 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kang-Ling Wang 臨床試驗科
- Chern-En Chiang 臨床試驗科
- 張皓智 Division of Cardiovascular Diseases
- 蔡依霖 Division of Cardiovascular Diseases
- 張俊欽 Division of Cardiovascular Diseases
- 黃偉銘 Division of Cardiovascular Diseases
- 黃少嵩 Division of Family Medicine
- Hao-min Cheng 教學部
- Wen-Chung Yu Division of Cardiovascular Diseases
- 吳承學 Division of General Internal Medicine
- Tse-Min Lu Division of Family Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 朱志生 Division of Cardiovascular Diseases
- 黃天祈 Division of Cardiovascular Diseases
- Chun-Yuan Chu Division of Cardiovascular Diseases
- 吳韋璁 Division of Cardiovascular Diseases
- 張建偉 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 余法昌 Division of Cardiovascular Diseases
- 林岳鴻 Division of Cardiovascular Diseases
- 黃文弘 Division of Cardiovascular Diseases
- 藍偉仁 Division of Cardiovascular Diseases
- 宋國慈 Division of Cardiovascular Diseases
- 顏志軒 Division of Cardiovascular Diseases
- 蕭智忠 Division of Cardiovascular Diseases
- 蔡瑞鵬 Division of Cardiovascular Diseases
- 簡世杰 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 鄭宇倫 Division of Cardiovascular Diseases
- 陳志維 Division of Cardiovascular Diseases
- 洪元 Division of Cardiovascular Diseases
- 陳彥舟 Division of Cardiovascular Diseases
- Yung-Ta Kao Division of Cardiovascular Diseases
- Chien-Yi Hsu Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 劉文正 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
280 participants
-
Global
6950 participants
